Citadel Advisors »

Haemonetics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Haemonetics shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Haemonetics

Tip: Access up to 7 years of quarterly data

All positions including Haemonetics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Haemonetics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $11M 12M 0.92
2023-09-30 $5.2M 6.0M 0.87

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Broadcom Call Option (AVGO)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl C Call Option (GOOG)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl A Call Option (GOOGL)

View all positions for Citadel Advisors

Top funds holding Haemonetics

Tenor Capital Management
Franklin Resources
Bank Of Montreal
Readystate Asset Management
MacKay Shields
DeepCurrents Investment Group
Aviva
Braidwell
Osterweis Capital Management
Wells Fargo & Company
Citadel Advisors
Verition Fund Management
New York State Common Retirement Fund
Bnp Paribas Investment Partners
BlackRock

View all funds holding Haemonetics